Overview Amneal Pharmaceuticals, Inc. (the Company, we, us, or our) is a diversified, global biopharmaceutical company that develops, manufactures, markets, and distributes a diverse portfolio of essential medicines. Our Affordable Medicines segment includes retail generics, injectables, and biosimilars. In our Specialty segment, we offer a portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders. Through our AvKARE segment, we are a distributor of...
Q2 FY2026 — expected 2026-08-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-27 | 2025-12-31 | 0001723128-26-000011 | EDGAR | 96K words |
| 2025-02-28 | 2024-12-31 | 0001723128-25-000012 | EDGAR | — |
| 2024-03-14 | 2023-12-31 | 0001723128-24-000014 | EDGAR | — |
| 2023-03-03 | 2022-12-31 | 0001723128-23-000009 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001723128-22-000006 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001723128-21-000013 | EDGAR | — |
| 2020-03-02 | 2019-12-31 | 0001564590-20-008179 | EDGAR | — |
| 2019-03-01 | 2018-12-31 | 0001723128-19-000028 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001723128-18-000005 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001723128-25-000062 | EDGAR | 27K words |
| 2025-08-07 | 2025-06-30 | 0001723128-25-000047 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0001723128-25-000022 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001723128-24-000042 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001723128-24-000032 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001723128-24-000021 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001723128-23-000044 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001723128-23-000031 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001723128-23-000020 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0001723128-22-000039 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001723128-22-000034 | EDGAR | — |
| 2022-05-06 | 2022-03-31 | 0001723128-22-000016 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-27 | 0001723128-26-000008 | EDGAR | 9K words |
| 2026-02-03 | 0001628280-26-004738 | EDGAR | — |
| 2026-01-28 | 0001628280-26-003842 | EDGAR | — |
| 2026-01-13 | 0001723128-26-000003 | EDGAR | — |
| 2025-10-30 | 0001723128-25-000059 | EDGAR | — |
| 2025-08-05 | 0001723128-25-000037 | EDGAR | — |
| 2025-08-01 | 0000950103-25-009701 | EDGAR | — |
| 2025-07-24 | 0000950103-25-009253 | EDGAR | — |
| 2025-07-21 | 0000950103-25-009025 | EDGAR | — |
| 2025-07-21 | 0001723128-25-000033 | EDGAR | — |
140 total filings indexed. 109 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001723128 |
| Ticker | AMRX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.amneal.com |
| Listed | 2018-05-07 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report